Michael Scolaro

Michael Scolaro

Sep 27, 2017

Group 6 Copy 118
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Help us pioneer stem cell therapy for giraffe!

Arthritis is common in geriatric giraffe. Cheyenne Mountain Zoo is uniquely suited to help find better arthritis...

Viral Causes of Lung Cancer

We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

Identification of Pancreatic Cancer Specific Tumor Markers for Early Detection

Pancreatic cancer is the third leading cause of cancer-related death in the US, and expected to become the...

Backer Badge Funded